Skip to content
Research Article Open access CC BY 4.0

Anticancer Efficacy of Thevetia peruviana (Pers.) K. Schum. Extracts on Triple Negative Human Breast Cancer Cell Line

S. Rajhans, K. Bhadresha, D. K. Yadav, R. M. Rawal, H. A. Pandya, A. U. Mankad

European Journal of Medicinal Plants · pp. 64–69 · Published 19 Feb 2020

10.9734/ejmp/2020/v31i130206

Abstract

In this 21st century cancer has become the second big reason for death next to heart attack in both developed and the developing countries.  Worldwide, there are almost 2.1 million newly diagnosed breast cancer cases in 2018, accounting for 1 in 4 cancer cases among women. Triple Negative Human Breast Cancer is one of the types of human breast cancer. The plant extracts of Thevetia peruviana (Pers.) K. Schum. has been used against the Triple Negative Human Breast Cancer cell line MDA-MB-231 for the current experiment All the 5 parts (leaf, stem, flower, fruit and seed) had been selected for the experiment and the extracts of the various parts were made in hydro-alcoholic solvent i.e. methanol: Water.

Thevetia peruviana (Pers.) K. Schum triple negative human breast cancer MDA-MB-231 plant parts soxhlet extraction.

Cited by 1

Effect of Thevetia peruviana Seeds Extract for Microbial Pathogens and Cancer Control

T.M. Abdelghany, Reham Yahya, Marwah M. Bakri · International Journal of Pharmacology · 2021

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.